IPN Ipsen SA

IPSEN - Buy-back programme - Art 5 of MAR - Week 24 - 2023

IPSEN - Buy-back programme - Art 5 of MAR - Week 24 - 2023

 Aggregated presentation by day and by market

Name of issuerIdentification code of issuer (Legal Entity Identifier)Day of transactionIdentification code of financial instrumentAggregated daily volume (in number of shares)Daily weighted average price of the purchased shares *Market (MIC Code)
IPSEN549300M6SGDPB4Z94P1112/06/2023FR0010259150260111.72AQEU
IPSEN549300M6SGDPB4Z94P1112/06/2023FR0010259150960111.40CEUX
IPSEN549300M6SGDPB4Z94P1112/06/2023FR0010259150588111.57TQEX
IPSEN549300M6SGDPB4Z94P1112/06/2023FR00102591502,892111.57XPAR
IPSEN549300M6SGDPB4Z94P1113/06/2023FR0010259150808111.08AQEU
IPSEN549300M6SGDPB4Z94P1113/06/2023FR00102591501,143111.13CEUX
IPSEN549300M6SGDPB4Z94P1113/06/2023FR0010259150669111.22TQEX
IPSEN549300M6SGDPB4Z94P1113/06/2023FR00102591503,430111.15XPAR
IPSEN549300M6SGDPB4Z94P1114/06/2023FR0010259150659111.15AQEU
IPSEN549300M6SGDPB4Z94P1114/06/2023FR00102591501,148111.04CEUX
IPSEN549300M6SGDPB4Z94P1114/06/2023FR0010259150398111.14TQEX
IPSEN549300M6SGDPB4Z94P1114/06/2023FR00102591504,195111.03XPAR
IPSEN549300M6SGDPB4Z94P1115/06/2023FR00102591501,034110.72AQEU
IPSEN549300M6SGDPB4Z94P1115/06/2023FR00102591501,504110.67CEUX
IPSEN549300M6SGDPB4Z94P1115/06/2023FR0010259150584110.65TQEX
IPSEN549300M6SGDPB4Z94P1115/06/2023FR00102591504,678110.57XPAR
IPSEN549300M6SGDPB4Z94P1116/06/2023FR0010259150210111.17AQEU
IPSEN549300M6SGDPB4Z94P1116/06/2023FR0010259150387111.89CEUX
IPSEN549300M6SGDPB4Z94P1116/06/2023FR0010259150223112.19TQEX
IPSEN549300M6SGDPB4Z94P1116/06/2023FR00102591501,947112.10XPAR
       
* Two-digit rounding after the decimal TOTAL27,717111.13 



Attachment



EN
20/06/2023

Underlying

IPNIpsen SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ipsen SA

 PRESS RELEASE
Free
IPN IPSEN SA

Ipsen receives positive CHMP opinion for Cabometyx® in previously trea...

Ipsen receives positive CHMP opinion for Cabometyx® in previously treated advanced neuroendocrine tumors If approved, Cabometyx® would be the first and only systemic therapy approved in the European Union for previously treated neuroendocrine tumors, regardless of tumor site, grade or previous non-somatostatin analogue-based systemic therapy1,2Recommendation based on CABINET Phase III trial results, which demonstrated statistically significant and clinically meaningful reductions in risk of disease progression or death with Cabometyx versus placebo3,4European Commission decision expected Q3...

June 20, 2025 1 EN
 PRESS RELEASE
Free
IPN IPSEN SA

Ipsen reçoit un avis positif du CHMP pour Cabometyx® dans les tumeurs ...

Ipsen reçoit un avis positif du CHMP pour Cabometyx® dans les tumeurs neuroendocrines avancées précédemment traitées S’il est approuvé, Cabometyx® sera le premier et unique traitement systémique autorisé dans l’Union européenne pour les tumeurs neuroendocrines précédemment traitées, indépendamment de la localisation de la tumeur, de sa gravité et de l’administration ou non d’un traitement systémique auparavant, autre qu’un traitement par analogue de la somatostatine1, 2Les recommandations se basent sur les résultats de l’étude de Phase III CABINET qui ont démontré une réduction significativ...

June 20, 2025 1 EN
 PRESS RELEASE
Free
IPN IPSEN SA

IPSEN - Buy-back programme - Art 5 of MAR - Week 24 - 2025

IPSEN - Buy-back programme - Art 5 of MAR - Week 24 - 2025 Aggregated presentation by day and by market Statement of transactions in own shares from June 09th to June 13th 2025       Name of the issuerIdentity code of the issuer (Legal Entity Identifier) Day of the transactionIdentity code of the financial instrument Total daily volume (in number of shares)Daily weighted average purchase price of the sharesMarket         (MIC Code) IPSEN549300M6SGDPB4Z94P1109/06/2025FR0010259150   320   104,26875AQEUIPSEN549300M6SGDPB4Z94P1109/06/2025FR0010259150  1 050   104,1799CCXEIPSEN549300M6SGDPB4Z94P...

June 17, 2025 1 EN
 PRESS RELEASE
Free
IPN IPSEN SA

IPSEN - Achats effectués dans les conditions de l'Article 5 du Règleme...

IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 24 - 2025 Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 09 juin au 13 juin 2025       Nom de l'émetteurCode identifiant de l'émetteur (code LEI)Jour de la transactionCode identifiant de l'instrument financierVolume total journalier (en nombre de titres)Prix pondéré moyen journalier d'acquisitionCode identifiant marchéIPSEN549300M6SGDPB4Z94P1109/06/2025FR0010259150   320   104,26875AQEUIPSEN549300M6SGDPB4Z94P1109/06/2025FR0010259150  1 050   104,1...

June 17, 2025 1 EN
 PRESS RELEASE
Free
IPN IPSEN SA

IPSEN - Buy-back programme - Art 5 of MAR - Week 23 - 2025

IPSEN - Buy-back programme - Art 5 of MAR - Week 23 - 2025 Aggregated presentation by day and by market Statement of transactions in own shares from June 2nd to June 6th 2025       Name of the issuerIdentity code of the issuer (Legal Entity Identifier) Day of the transactionIdentity code of the financial instrument Total daily volume (in number of shares)Daily weighted average purchase price of the sharesMarket         (MIC Code) IPSEN549300M6SGDPB4Z94P1102/06/2025FR0010259150   294   102,63197AQEUIPSEN549300M6SGDPB4Z94P1102/06/2025FR0010259150   929   102,90904CCXEIPSEN549300M6SGDPB4Z94P11...

June 13, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch